Exane Derivatives’s AngioDynamics ANGO Stock Holding History

Exane Derivatives’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,495	Closed	-$41.2K	–	1019
2021 Q4	$41.2K	Buy	1,495 +1,465	+4,883%	+$40.4K	0.01%	516
2021 Q3	$778	Sell	30 -5,626	-99%	-$150K	﹤0.01%	894
2021 Q2	$155K	Sell	5,656 -3,472	-38%	-$84.8K	0.04%	472
2021 Q1	$214K	Buy	9,128 +1,245	+16%	+$25.2K	0.06%	289
2020 Q4	$121K	Buy	+7,883	New	+$100K	0.04%	371

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Exane Derivatives's ANGO Position: Q1 2022 in Review

Exane Derivatives sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 1,495 shares — an estimated $41.2K sold.

Exane Derivatives first reported a position in ANGO in Q4 2020 and held it in 5 quarters. The position peaked at $214K in Q1 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

Exane Derivatives reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
Exane Derivatives sold 1,495 AngioDynamics shares in Q1 2022, an estimated $41.2K.
Exane Derivatives first reported a position in AngioDynamics in Q4 2020 and held it in 5 quarters.
Exane Derivatives's AngioDynamics position peaked at $214K in Q1 2021.
144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.